WallStreetZenWallStreetZen

NASDAQ: CELU
Celularity Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their CELU stock forecasts and price targets.

Forecast return on equity

Is CELU forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is CELU forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CELU revenue forecast

What is CELU's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$19.6M+32.74%
Avg 2 year Forecast
$65.5M+343.2%
Avg 3 year Forecast
$70.5M+376.54%
CELU's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CELU revenue growth forecast

How is CELU forecast to perform vs Biotechnology companies and vs the US market?
Company
73.55%
Industry
37.04%
Market
9.92%
CELU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CELU's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CELU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELU$3.07N/AN/A
CDTX$13.00$120.00+823.08%Buy
MURA$3.53$13.00+268.27%Strong Buy
THTX$1.30N/AN/A
KRON$0.98$4.25+333.67%Strong Buy
View Top Biotech Stocks

Celularity Stock Forecast FAQ

What is CELU's revenue growth forecast for 2024-2026?

(NASDAQ: CELU) Celularity's forecast annual revenue growth rate of 73.55% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Celularity's revenue in 2024 is $14,788,000.On average, 1 Wall Street analysts forecast CELU's revenue for 2024 to be $380,393,359, with the lowest CELU revenue forecast at $380,393,359, and the highest CELU revenue forecast at $380,393,359. On average, 1 Wall Street analysts forecast CELU's revenue for 2025 to be $1,270,044,869, with the lowest CELU revenue forecast at $1,270,044,869, and the highest CELU revenue forecast at $1,270,044,869.

In 2026, CELU is forecast to generate $1,365,579,217 in revenue, with the lowest revenue forecast at $1,365,579,217 and the highest revenue forecast at $1,365,579,217.

If you're new to stock investing, here's how to buy Celularity stock.

What is CELU's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CELU) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CELU's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CELU) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.